What’s happening to the UK’s first vaccine?

In a year that has seen a surge in vaccine-preventable diseases, the UK has seen just one new vaccine announced: a vaccine developed by a British company that was developed for use in Europe.However, this is the first of many similar vaccines that could be released over the coming years, and the potential for the […]

Read More →

Australian government launches program to combat online fraud

The Australian Financial Press (AFP) has released the first of its five annual report on the Australian Government’s digital strategy.Read more…In its report, titled ‘Digital in the Australian Public Interest’, the AFP found that Australians are spending $4.6 billion on digital media services annually, with a significant amount of this being spent on digital content […]

Read More →

PSS to send up to 30% of its annual production to PSS by 2021

By JASON BRUCE, APGENRAH MOHAMED, ANDERSON ALFRED and BRENT E. KLEINERKAB article PSS, a maker of precision-guided munitions, has announced plans to buy about 20% of the company’s production.The move will add to the pressure on the embattled company as the company continues to deal with a variety of health and safety issues.PSS has been […]

Read More →

Why are there so many deaths in New York City from coronavirus?

New York, NY–(BUSINESS WIRE)–Novavax, Inc., a biopharmaceutical company developing a novel antiviral drug that is approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of acute and chronic obstructive pulmonary disease (COPD), announced today that the company has identified over 500 new cases of coronaviruses worldwide and has more than […]

Read More →